Colaxin may be available in the countries listed below.
Ingredient matches for Colaxin
Cefalexin is reported as an ingredient of Colaxin in the following countries:
- Myanmar
International Drug Name Search
Colaxin may be available in the countries listed below.
Cefalexin is reported as an ingredient of Colaxin in the following countries:
International Drug Name Search
Amopicillin may be available in the countries listed below.
Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Amopicillin in the following countries:
International Drug Name Search
Teleminsoft may be available in the countries listed below.
Bisacodyl is reported as an ingredient of Teleminsoft in the following countries:
International Drug Name Search
Piperacillin/Tazobactam Hexal may be available in the countries listed below.
Piperacillin is reported as an ingredient of Piperacillin/Tazobactam Hexal in the following countries:
Tazobactam is reported as an ingredient of Piperacillin/Tazobactam Hexal in the following countries:
International Drug Name Search
Acide citrique may be available in the countries listed below.
Acide citrique (DCF) is known as Citric Acid in the US.
International Drug Name Search
Glossary
DCF | Dénomination Commune Française |
In the US, Celexa (citalopram systemic) is a member of the drug class selective serotonin reuptake inhibitors and is used to treat Anxiety and Stress, Body Dysmorphic Disorder, Depression, Generalized Anxiety Disorder, Obsessive Compulsive Disorder, Panic Disorder, Postpartum Depression, Premenstrual Dysphoric Disorder, Trichotillomania and Vulvodynia.
US matches:
Citalopram hydrobromide (a derivative of Citalopram) is reported as an ingredient of Celexa in the following countries:
International Drug Name Search
Cirizine may be available in the countries listed below.
Cetirizine dihydrochloride (a derivative of Cetirizine) is reported as an ingredient of Cirizine in the following countries:
International Drug Name Search
Ridinfect may be available in the countries listed below.
Roxithromycin is reported as an ingredient of Ridinfect in the following countries:
International Drug Name Search
Keycarbazin may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Nicarbazin is reported as an ingredient of Keycarbazin in the following countries:
International Drug Name Search
Cefatrex may be available in the countries listed below.
Cefapirin sodium salt (a derivative of Cefapirin) is reported as an ingredient of Cefatrex in the following countries:
International Drug Name Search
Itagil may be available in the countries listed below.
Buspirone hydrochloride (a derivative of Buspirone) is reported as an ingredient of Itagil in the following countries:
International Drug Name Search
Ratidin may be available in the countries listed below.
Ranitidine is reported as an ingredient of Ratidin in the following countries:
International Drug Name Search
Xalotina may be available in the countries listed below.
Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Xalotina in the following countries:
International Drug Name Search
Cyprotérone/Ethinylestradiol Ranbaxy may be available in the countries listed below.
Cyproterone 17α-acetate (a derivative of Cyproterone) is reported as an ingredient of Cyprotérone/Ethinylestradiol Ranbaxy in the following countries:
Ethinylestradiol is reported as an ingredient of Cyprotérone/Ethinylestradiol Ranbaxy in the following countries:
International Drug Name Search
Cedlips may be available in the countries listed below.
Oxatomide is reported as an ingredient of Cedlips in the following countries:
International Drug Name Search
Metaoxedrin SAD may be available in the countries listed below.
Phenylephrine hydrochloride (a derivative of Phenylephrine) is reported as an ingredient of Metaoxedrin SAD in the following countries:
International Drug Name Search
Ameproxen may be available in the countries listed below.
Naproxen sodium salt (a derivative of Naproxen) is reported as an ingredient of Ameproxen in the following countries:
International Drug Name Search
Puricap may be available in the countries listed below.
Anastrozole is reported as an ingredient of Puricap in the following countries:
International Drug Name Search
Liberanit may be available in the countries listed below.
Acetic Acid 4% (a derivative of Acetic Acid) is reported as an ingredient of Liberanit in the following countries:
International Drug Name Search
Litalir may be available in the countries listed below.
Hydroxycarbamide is reported as an ingredient of Litalir in the following countries:
International Drug Name Search
Mediprost may be available in the countries listed below.
Alprostadil alfadex (a derivative of Alprostadil) is reported as an ingredient of Mediprost in the following countries:
International Drug Name Search
Penegra may be available in the countries listed below.
Sildenafil citrate (a derivative of Sildenafil) is reported as an ingredient of Penegra in the following countries:
International Drug Name Search
Pharmatex may be available in the countries listed below.
Benzalkonium chloride (a derivative of Benzalkonium) is reported as an ingredient of Pharmatex in the following countries:
International Drug Name Search
Amlodipino Davur may be available in the countries listed below.
Amlodipine mesilate (a derivative of Amlodipine) is reported as an ingredient of Amlodipino Davur in the following countries:
International Drug Name Search
Mirtazapina Ur may be available in the countries listed below.
Mirtazapine is reported as an ingredient of Mirtazapina Ur in the following countries:
International Drug Name Search
Tramadol Genfar may be available in the countries listed below.
Tramadol is reported as an ingredient of Tramadol Genfar in the following countries:
Tramadol hydrochloride (a derivative of Tramadol) is reported as an ingredient of Tramadol Genfar in the following countries:
International Drug Name Search
Captopril Stada may be available in the countries listed below.
Captopril is reported as an ingredient of Captopril Stada in the following countries:
International Drug Name Search
Cardicol may be available in the countries listed below.
Amlodipine besilate (a derivative of Amlodipine) is reported as an ingredient of Cardicol in the following countries:
International Drug Name Search
Trinacol may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Sulfadiazine is reported as an ingredient of Trinacol in the following countries:
Trimethoprim is reported as an ingredient of Trinacol in the following countries:
International Drug Name Search
Argi-U may be available in the countries listed below.
Arginine hydrochloride (a derivative of Arginine) is reported as an ingredient of Argi-U in the following countries:
International Drug Name Search
Blutal may be available in the countries listed below.
Chondroitin Polysulfate iron complex (a derivative of Chondroitin Polysulfate) is reported as an ingredient of Blutal in the following countries:
International Drug Name Search
Mitaprogen may be available in the countries listed below.
Flopropione is reported as an ingredient of Mitaprogen in the following countries:
International Drug Name Search
AteHexal may be available in the countries listed below.
Atenolol is reported as an ingredient of AteHexal in the following countries:
International Drug Name Search
Pegabtanib Octasodium may be available in the countries listed below.
Pegabtanib Octasodium (USAN) is known as Pegaptanib in the US.
International Drug Name Search
Glossary
USAN | United States Adopted Name |
In some countries, this medicine may only be approved for veterinary use.
Rec.INN
0115550-35-1
C17-H19-F-N4-O4
362
Antibacterial: Gyrase inhibitor
9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[3,2,1-ij][4,1,2,]benzoxadiazine-6-carboxylic acid
9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyridol[3,2,1-ij]benzoxadiazine-6-carboxylic acid (WHO)
International Drug Name Search
Glossary
BAN | British Approved Name |
IS | Inofficial Synonym |
OS | Official Synonym |
PH | Pharmacopoeia Name |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
WHO | World Health Organization |
Tiogam may be available in the countries listed below.
Tiaprofenic Acid is reported as an ingredient of Tiogam in the following countries:
International Drug Name Search
Chemmart Cephalexin may be available in the countries listed below.
Cefalexin monohydrate (a derivative of Cefalexin) is reported as an ingredient of Chemmart Cephalexin in the following countries:
International Drug Name Search
Ermac may be available in the countries listed below.
Erythromycin is reported as an ingredient of Ermac in the following countries:
International Drug Name Search
Min-a-pon may be available in the countries listed below.
Nimesulide is reported as an ingredient of Min-a-pon in the following countries:
International Drug Name Search
Rozalin may be available in the countries listed below.
Dorzolamide is reported as an ingredient of Rozalin in the following countries:
International Drug Name Search
Calvepen may be available in the countries listed below.
Phenoxymethylpenicillin calcium (a derivative of Phenoxymethylpenicillin) is reported as an ingredient of Calvepen in the following countries:
International Drug Name Search
Cetirizine dihydrochloride (a derivative of Cetirizine) is reported as an ingredient of Cetirizine hydrochloride and Pseudoephedrine hydrochloride in the following countries:
Pseudoephedrine hydrochloride (a derivative of Pseudoephedrine) is reported as an ingredient of Cetirizine hydrochloride and Pseudoephedrine hydrochloride in the following countries:
International Drug Name Search
Lastet S may be available in the countries listed below.
Etoposide is reported as an ingredient of Lastet S in the following countries:
International Drug Name Search
Triocaps may be available in the countries listed below.
Chlorphenamine maleate (a derivative of Chlorphenamine) is reported as an ingredient of Triocaps in the following countries:
Phenylephrine hydrochloride (a derivative of Phenylephrine) is reported as an ingredient of Triocaps in the following countries:
International Drug Name Search
Tofiel may be available in the countries listed below.
Tofisopam is reported as an ingredient of Tofiel in the following countries:
International Drug Name Search
Parkines may be available in the countries listed below.
Trihexyphenidyl hydrochloride (a derivative of Trihexyphenidyl) is reported as an ingredient of Parkines in the following countries:
International Drug Name Search
Percof may be available in the countries listed below.
Levodropropizine is reported as an ingredient of Percof in the following countries:
International Drug Name Search
Benclart may be available in the countries listed below.
Glibenclamide is reported as an ingredient of Benclart in the following countries:
International Drug Name Search
Perindopril Hexal may be available in the countries listed below.
Perindopril is reported as an ingredient of Perindopril Hexal in the following countries:
International Drug Name Search
Tantum Lemon may be available in the countries listed below.
Benzydamine hydrochloride (a derivative of Benzydamine) is reported as an ingredient of Tantum Lemon in the following countries:
International Drug Name Search
Lubrilax may be available in the countries listed below.
Sodium Picosulfate is reported as an ingredient of Lubrilax in the following countries:
International Drug Name Search
In the US, Mutamycin (mitomycin systemic) is a member of the drug class antibiotics/antineoplastics and is used to treat Bladder Cancer, Pancreatic Cancer and Stomach Cancer.
US matches:
Mitomycin is reported as an ingredient of Mutamycin in the following countries:
International Drug Name Search
Goforan may be available in the countries listed below.
Cefotaxime sodium salt (a derivative of Cefotaxime) is reported as an ingredient of Goforan in the following countries:
International Drug Name Search
Risperanne may be available in the countries listed below.
Risperidone is reported as an ingredient of Risperanne in the following countries:
International Drug Name Search
Comet may be available in the countries listed below.
Metformin hydrochloride (a derivative of Metformin) is reported as an ingredient of Comet in the following countries:
International Drug Name Search
Locoid C may be available in the countries listed below.
Chlorquinaldol is reported as an ingredient of Locoid C in the following countries:
Hydrocortisone 17α-butyrate (a derivative of Hydrocortisone) is reported as an ingredient of Locoid C in the following countries:
International Drug Name Search
Rasagiline mesylate may be available in the countries listed below.
Rasagiline mesylate (USAN) is known as Rasagiline in the US.
International Drug Name Search
Glossary
USAN | United States Adopted Name |
Minims Mydriatics and Cylcoplegics may be available in the countries listed below.
Cyclopentolate hydrochloride (a derivative of Cyclopentolate) is reported as an ingredient of Minims Mydriatics and Cylcoplegics in the following countries:
International Drug Name Search
Half Securon may be available in the countries listed below.
UK matches:
Verapamil hydrochloride (a derivative of Verapamil) is reported as an ingredient of Half Securon in the following countries:
International Drug Name Search
Glossary
SPC | Summary of Product Characteristics (UK) |
Metronidazole Biosedra may be available in the countries listed below.
Metronidazole is reported as an ingredient of Metronidazole Biosedra in the following countries:
International Drug Name Search
Claricide may be available in the countries listed below.
Clarithromycin is reported as an ingredient of Claricide in the following countries:
International Drug Name Search
Lecetrin may be available in the countries listed below.
Levocetirizine dihydrochloride (a derivative of Levocetirizine) is reported as an ingredient of Lecetrin in the following countries:
International Drug Name Search
Ectren may be available in the countries listed below.
Quinapril hydrochloride (a derivative of Quinapril) is reported as an ingredient of Ectren in the following countries:
International Drug Name Search
GenRX Paroxetine may be available in the countries listed below.
Paroxetine hydrochloride (a derivative of Paroxetine) is reported as an ingredient of GenRX Paroxetine in the following countries:
International Drug Name Search
Atorva may be available in the countries listed below.
Atorvastatin calcium (a derivative of Atorvastatin) is reported as an ingredient of Atorva in the following countries:
International Drug Name Search
Farmasal may be available in the countries listed below.
Acetylsalicylic Acid is reported as an ingredient of Farmasal in the following countries:
International Drug Name Search
Cazmar may be available in the countries listed below.
Retinol is reported as an ingredient of Cazmar in the following countries:
International Drug Name Search
Ardeyhepan may be available in the countries listed below.
Silibinin is reported as an ingredient of Ardeyhepan in the following countries:
International Drug Name Search
Bilol comp. may be available in the countries listed below.
Bisoprolol fumarate (a derivative of Bisoprolol) is reported as an ingredient of Bilol comp. in the following countries:
Hydrochlorothiazide is reported as an ingredient of Bilol comp. in the following countries:
International Drug Name Search
Metoprolol-ratiopharm comp. may be available in the countries listed below.
Hydrochlorothiazide is reported as an ingredient of Metoprolol-ratiopharm comp. in the following countries:
Metoprolol tartrate (a derivative of Metoprolol) is reported as an ingredient of Metoprolol-ratiopharm comp. in the following countries:
International Drug Name Search
Balminil DM + Expectorant may be available in the countries listed below.
Dextromethorphan hydrobromide (a derivative of Dextromethorphan) is reported as an ingredient of Balminil DM + Expectorant in the following countries:
Guaifenesin is reported as an ingredient of Balminil DM + Expectorant in the following countries:
International Drug Name Search
Poshinlen may be available in the countries listed below.
Dipyridamole is reported as an ingredient of Poshinlen in the following countries:
International Drug Name Search
Framex may be available in the countries listed below.
Fluoxetine is reported as an ingredient of Framex in the following countries:
International Drug Name Search
Purinase may be available in the countries listed below.
Allopurinol is reported as an ingredient of Purinase in the following countries:
International Drug Name Search
Citarabina Pfizer may be available in the countries listed below.
Cytarabine is reported as an ingredient of Citarabina Pfizer in the following countries:
International Drug Name Search
Atrederm may be available in the countries listed below.
Tocopherol, α- acetate (a derivative of Tocopherol, α-) is reported as an ingredient of Atrederm in the following countries:
Tretinoin is reported as an ingredient of Atrederm in the following countries:
International Drug Name Search
Heart Gold may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Ivermectin is reported as an ingredient of Heart Gold in the following countries:
International Drug Name Search
Livarole may be available in the countries listed below.
Ketoconazole is reported as an ingredient of Livarole in the following countries:
International Drug Name Search
Rec.INN
D08AJ08
0000121-54-0
C27-H42-Cl-N-O2
448
Antiseptic
Disinfectant
Benzenemethanaminium, N,N-dimethyl-N-[2-[2-[4-(1,1,3,3-tetramethylbutyl)phenoxy]ethoxy]ethyl]-, chloride
International Drug Name Search
Glossary
BAN | British Approved Name |
DCIT | Denominazione Comune Italiana |
OS | Official Synonym |
PH | Pharmacopoeia Name |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
Mucolica may be available in the countries listed below.
Ambroxol hydrochloride (a derivative of Ambroxol) is reported as an ingredient of Mucolica in the following countries:
International Drug Name Search
Coronair may be available in the countries listed below.
Dipyridamole is reported as an ingredient of Coronair in the following countries:
International Drug Name Search
Retrovir AZT may be available in the countries listed below.
Zidovudine is reported as an ingredient of Retrovir AZT in the following countries:
International Drug Name Search
In the US, Methylin (methylphenidate systemic) is a member of the drug class CNS stimulants and is used to treat ADHD and Narcolepsy.
US matches:
Methylphenidate is reported as an ingredient of Methylin in the following countries:
Methylphenidate hydrochloride (a derivative of Methylphenidate) is reported as an ingredient of Methylin in the following countries:
International Drug Name Search
Esypan may be available in the countries listed below.
Clonazepam is reported as an ingredient of Esypan in the following countries:
International Drug Name Search
UNIPHYLLIN® CONTINUS® 200, 300 and 400 mg prolonged release tablets
Tablets containing 200, 300 or 400 mg of Theophylline.
For excipients, see 6.1
Prolonged release tablets
|
|
|
|
|
|
For the treatment and prophylaxis of bronchospasm associated with asthma, chronic obstructive pulmonary disease and chronic bronchitis. Also indicated for the treatment of left ventricular and congestive cardiac failure.
Route of Administration
Oral
The tablets should be swallowed whole and not crushed or chewed. Crushing or chewing the tablets may lead to a rapid release of theophylline with the potential for toxicity. Patients vary in their response to xanthines and it may be necessary to titrate the dose on an individual basis.
The usual maintenance dose for adults and elderly patients is 200 mg 12 hourly. This may be titrated to either 300 mg or 400 mg dependent on the therapeutic response. Plasma theophylline concentrations should ideally be maintained between 5 and 15 mg/l. A plasma level of 5 mg/l probably represents the lower level of clinical effectiveness. Significant adverse reactions are usually seen at plasma theophylline levels greater than 20 mg/l. Patients may require monitoring of plasma theophylline levels when higher dosages are prescribed or when co-administered with medication that reduces theophylline clearance.
Children: The maintenance dose is 9 mg/kg twice daily. Some children with chronic asthma require and tolerate much higher doses (10-16 mg/kg twice daily). Lower dosages (based on usual adult dose) may be required for adolescents.
It may be appropriate to administer a larger evening or morning dose in some patients, in order to achieve optimum therapeutic effect when symptoms are most severe e.g. at the time of the 'morning dip' in lung function.
In patients whose night time or day time symptoms persist despite other therapy and who are not currently receiving theophylline, then the total daily requirement of UNIPHYLLIN CONTINUS tablets (as specified above) may be added to their treatment regimen as either a single evening or morning dose.
Porphyria; hypersensitivity to xanthines or any of the tablet constituents; concomitant administration with ephedrine in children.
The patient's response to therapy should be carefully monitored – worsening of asthma symptoms requires medical attention.
Use with caution in patients with cardiac disease, peptic ulcer, hyperthyroidism, severe hypertension, hepatic dysfunction, chronic alcoholism or acute febrile illness.
Caution should be exercised in elderly males with pre-existing partial outflow obstruction, such as prostatic enlargement, due to risk of urinary retention.
The half-life of theophylline may be prolonged in the elderly and in patients with heart failure, hepatic impairment or viral infections. Toxic accumulation may occur (see Section 4.9 Overdose). A reduction of dosage may be necessary in the elderly patient.
The hypokalaemia resulting from beta agonist therapy, steroids, diuretics and hypoxia may be potentiated by xanthines. Particular care is advised in patients suffering from severe asthma who require hospitalisation. It is recommended that serum potassium levels are monitored in such situations.
Severe side effects (hypertonia, convulsions, supraventricular tachycardia) may indicate serum concentrations of theophylline above therapeutic levels. Serum concentrations should be checked urgently and a decrease in the dose of theophylline may be required.
Alternative treatment is advised for patients with a history of seizure activity.
It is not possible to ensure bioequivalence between different prolonged release theophylline products. Therefore patients, once titrated to an effective dose, should not be changed from one prolonged release theophylline preparation to a different prolonged release preparation without re-titration and clinical assessment.
The following increase clearance and it may therefore be necessary to increase dosage to ensure a therapeutic effect: aminoglutethimide, carbamazepine, isoprenaline, moracizine, phenytoin, rifampicin, ritonavir, sulphinpyrazone, barbiturates and hypericum perforatum. Plasma concentrations of theophylline can be reduced by concomitant use of the herbal remedy St John's Wort (hypericum perforatum). Smoking and alcohol consumption can also increase clearance of theophylline.
The following reduce clearance and a reduced dosage may therefore be necessary to avoid side-effects: allopurinol, carbimazole, cimetidine, ciprofloxacin, clarithromycin, diltiazem, disulfiram, erythromycin, fluconazole, interferon, isoniazid, methotrexate, mexiletine, nizatidine, norfloxacin, oxpentifylline, propafenone, propranolol, ofloxacin, thiabendazole, verapamil, viloxazine hydrochloride and oral contraceptives (see Section 4.9 Overdose). The concomitant use of theophylline and fluvoxamine should usually be avoided. Where this is not possible, patients should have their theophylline dose halved and plasma theophylline should be monitored closely.
Factors such as viral infections, liver disease and heart failure also reduce theophylline clearance (see Section 4.9 Overdose). There are conflicting reports concerning the potentiation of theophylline by influenza vaccine and physicians should be aware that interaction may occur. A reduction in dosage may be necessary in elderly patients. Thyroid disease or associated treatment may alter theophylline plasma levels. There is also a pharmacological interaction with adenosine, benzodiazepines, halothane, lomustine and lithium and these drugs should be used with caution.
Theophylline may decrease steady state phenytoin levels.
Xanthines can potentiate hypokalaemia resulting from beta2 agonist therapy, steroids, diuretics and hypoxia. Particular caution is advised in severe asthma. It is recommended that serum potassium levels are monitored in such situations.
Co-administration with β-blockers may cause antagonism of bronchodilation; with ketamine may cause reduced convulsive threshold; with doxapram may cause increased CNS stimulation.
There are no adequate data from well controlled studies of the use of theophylline in pregnant women. Theophylline has been reported to give rise to teratogenic effects in mice, rats and rabbits (See section 5.3). The potential risk for humans is unknown. Theophylline should not be administered during pregnancy unless clearly necessary. Theophylline is secreted in breast milk, and may be associated with irritability in the infant, therefore it should only be given to breast feeding women when the anticipated benefits outweigh the risk to the child.
No known effects.
The following adverse drug reactions have been reported in the post-marketing setting for theophylline. Frequencies of “not known” have been assigned as accurate frequencies cannot be estimated from the available clinical trial data.
|
|
| |
| |
|
|
|
|
| |
| |
|
|
| |
| |
| |
|
|
| |
| |
|
|
| |
| |
| |
| |
| |
|
|
| |
|
|
|
* Please refer to section 4.4 as theophylline may induce urinary retention in elderly males with pre-existing partial outflow obstruction.
Over 3 g could be serious in an adult (40 mg/kg in a child). The fatal dose may be as little as 4.5 g in an adult (60 mg/kg in a child), but is generally higher.
Symptoms
Warning: Serious features may develop as long as 12 hours after overdosage with prolonged release formulations.
Alimentary features: Nausea, vomiting (which is often severe), epigastric pain and haematemesis. Consider pancreatitis if abdominal pain persists.
Neurological features: Restlessness, hypertonia, exaggerated limb reflexes and convulsions. Coma may develop in very severe cases.
Cardiovascular features: Sinus tachycardia is common. Ectopic beats and supraventricular and ventricular tachycardia may follow.
Metabolic features: Hypokalaemia due to shift of potassium from plasma into cells is common, can develop rapidly and may be severe. Hyperglycaemia, hypomagnesaemia and metabolic acidosis may also occur. Rhabdomyolysis may also occur.
Management
Activated charcoal or gastric lavage should be considered if a significant overdose has been ingested within 1-2 hours. Repeated doses of activated charcoal given by mouth can enhance theophylline elimination. Measure the plasma potassium concentration urgently, repeat frequently and correct hypokalaemia. BEWARE! If large amounts of potassium have been given, serious hyperkalaemia may develop during recovery. If plasma potassium is low, then the plasma magnesium concentration should be measured as soon as possible.
In the treatment of ventricular arrhythmias, proconvulsant antiarrhythmic agents such as lignocaine (lidocaine) should be avoided because of the risk of causing or exacerbating seizures.
Measure the plasma theophylline concentration regularly when severe poisoning is suspected, until concentrations are falling. Vomiting should be treated with an antiemetic such as metoclopramide or ondansetron.
Tachycardia with an adequate cardiac output is best left untreated. Beta-blockers may be given in extreme cases but not if the patient is asthmatic. Control isolated convulsions with intravenous diazepam. Exclude hypokalaemia as a cause.
Theophylline is a bronchodilator. In addition it affects the function of a number of cells involved in the inflammatory processes associated with asthma and chronic obstructive airways disease. Of most importance may be enhanced suppressor, T-lymphocyte activity and reduction of eosinophil and neutrophil function. These actions may contribute to an anti-inflammatory prophylactic activity in asthma and chronic obstructive airways disease. Theophylline stimulates the myocardium and produces a diminution of venous pressure in congestive heart failure leading to marked increase in cardiac output.
Theophylline is well absorbed from UNIPHYLLIN CONTINUS tablets and at least 60% may be bound to plasma proteins. The main urinary metabolites are 1,3-dimethyl uric acid and 3-methylxanthine. About 10% is excreted unchanged.
In studies in which mice, rats and rabbits were dosed during the period of organogenesis, theophylline produced teratogenic effects.
Hydroxyethylcellulose
Povidone (K25)
Cetostearyl Alcohol
Macrogol 6000
Talc
Magnesium Stearate
Not applicable.
Three years.
Do not store above 25°C.
Blister packs consisting of aluminium foil sealed to 250 μm PVC with a PVdC coating of at least 40 gsm thickness, containing 56 tablets.
None.
Napp Pharmaceuticals Ltd
Cambridge Science Park
Milton Road
Cambridge CB4 0GW
PL 16950/0066-0068
200 mg - 23 August 1979/15 May 2003
300 mg – 22 February 1988/15 May 2003
400 mg – 29 October 1982/15 May 2003
22 March 2011
P
® UNIPHYLLIN, CONTINUS, NAPP and the Napp Device (logo) are Registered Trade Marks.
© 2010 – 2011 Napp Pharmaceuticals Ltd .
Paroxetin Sandoz may be available in the countries listed below.
Paroxetine hydrochloride (a derivative of Paroxetine) is reported as an ingredient of Paroxetin Sandoz in the following countries:
International Drug Name Search
Cregar may be available in the countries listed below.
Captopril is reported as an ingredient of Cregar in the following countries:
International Drug Name Search
Priom-D may be available in the countries listed below.
Domperidone is reported as an ingredient of Priom-D in the following countries:
Omeprazole is reported as an ingredient of Priom-D in the following countries:
International Drug Name Search
Poly Tears may be available in the countries listed below.
Dextran is reported as an ingredient of Poly Tears in the following countries:
Hypromellose is reported as an ingredient of Poly Tears in the following countries:
International Drug Name Search
Berodual may be available in the countries listed below.
Fenoterol is reported as an ingredient of Berodual in the following countries:
Fenoterol hydrobromide (a derivative of Fenoterol) is reported as an ingredient of Berodual in the following countries:
Ipratropium Bromide is reported as an ingredient of Berodual in the following countries:
International Drug Name Search
Prednisone Sandoz may be available in the countries listed below.
Prednisone is reported as an ingredient of Prednisone Sandoz in the following countries:
International Drug Name Search
Lamotrigine 1a Pharma may be available in the countries listed below.
Lamotrigine is reported as an ingredient of Lamotrigine 1a Pharma in the following countries:
International Drug Name Search
Cyclocaps Budesonid may be available in the countries listed below.
Budesonide is reported as an ingredient of Cyclocaps Budesonid in the following countries:
International Drug Name Search
Mylepsinum may be available in the countries listed below.
Primidone is reported as an ingredient of Mylepsinum in the following countries:
International Drug Name Search
Iromia may be available in the countries listed below.
Sodium Ferrous Citrate is reported as an ingredient of Iromia in the following countries:
International Drug Name Search
In the US, Activase (alteplase systemic) is a member of the drug class thrombolytics and is used to treat Heart Attack, Ischemic Stroke and Pulmonary Embolism.
US matches:
Alteplase is reported as an ingredient of Activase in the following countries:
International Drug Name Search
Josamine may be available in the countries listed below.
Glucosamine sulfate (a derivative of Glucosamine) is reported as an ingredient of Josamine in the following countries:
International Drug Name Search
Bezafibrat-ratiopharm may be available in the countries listed below.
Bezafibrate is reported as an ingredient of Bezafibrat-ratiopharm in the following countries:
International Drug Name Search
Ceftazidim Mylan may be available in the countries listed below.
Ceftazidime pentahydrate (a derivative of Ceftazidime) is reported as an ingredient of Ceftazidim Mylan in the following countries:
International Drug Name Search
Cefarinol may be available in the countries listed below.
Cefalexin monohydrate (a derivative of Cefalexin) is reported as an ingredient of Cefarinol in the following countries:
International Drug Name Search
Betahistine Walmark may be available in the countries listed below.
Betahistine dihydrochloride (a derivative of Betahistine) is reported as an ingredient of Betahistine Walmark in the following countries:
International Drug Name Search
Betabion may be available in the countries listed below.
Betaxolol hydrochloride (a derivative of Betaxolol) is reported as an ingredient of Betabion in the following countries:
Thiamine hydrochloride (a derivative of Thiamine) is reported as an ingredient of Betabion in the following countries:
International Drug Name Search
Apo-Clozapine may be available in the countries listed below.
Clozapine is reported as an ingredient of Apo-Clozapine in the following countries:
International Drug Name Search
Taenia-Passin may be available in the countries listed below.
Niclosamide is reported as an ingredient of Taenia-Passin in the following countries:
International Drug Name Search